Loading…

Drug-induced endocrine and metabolic disorders

Complex interactions exist amongst the various components of the neuroendocrine system in order to maintain homeostasis, energy balance and reproductive function. These components include the hypothalamus-pituitary- adrenal and -gonadal axes, the renin-angiotensin-aldosterone system, the sympathetic...

Full description

Saved in:
Bibliographic Details
Published in:Drug safety 2007-01, Vol.30 (3), p.215-245
Main Authors: MA, Ronald C. W, KONG, Alice P. S, CHAN, Norman, TONG, Peter C. Y, CHAN, Juliana C. N
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c441t-d814e02655a9ad77b32f1cbe71fc53790beec7315aeb1284c7202ce56d18d08f3
cites cdi_FETCH-LOGICAL-c441t-d814e02655a9ad77b32f1cbe71fc53790beec7315aeb1284c7202ce56d18d08f3
container_end_page 245
container_issue 3
container_start_page 215
container_title Drug safety
container_volume 30
creator MA, Ronald C. W
KONG, Alice P. S
CHAN, Norman
TONG, Peter C. Y
CHAN, Juliana C. N
description Complex interactions exist amongst the various components of the neuroendocrine system in order to maintain homeostasis, energy balance and reproductive function. These components include the hypothalamus-pituitary- adrenal and -gonadal axes, the renin-angiotensin-aldosterone system, the sympathetic nervous system and the pancreatic islets. These hormones, peptides and neurotransmitters act in concert to regulate the functions of many organs, notably the liver, muscles, kidneys, thyroid, bone, adrenal glands, adipocytes, vasculature, intestinal tract and gonads, through many intermediary pathways. Endocrine and metabolic disorders can arise from imbalance amongst numerous hormonal factors. These disturbances may be due to endogenous processes, such as increased secretion of hormones from a tumour, as well as exogenous drug administration. Drugs can cause endocrine abnormalities via different mechanisms, including direct alteration of hormone production, changes in the regulation of the hormonal axis, effects on hormonal transport, binding, and signalling, as well as similar changes to counter-regulatory hormone systems. Furthermore, drugs can affect the evaluation of endocrine parameters by causing interference with diagnostic tests. Common drug-induced endocrine and metabolic disorders include disorders of carbohydrate metabolism, electrolyte and calcium abnormalities, as well as drug-induced thyroid and gonadal disorders. An understanding of the proposed mechanisms of these drug effects and their evaluation and differential diagnosis may allow for more critical interpretation of the clinical observations associated with such disorders, better prediction of drug-induced adverse effects and better choices of and rationales for treatment.
doi_str_mv 10.2165/00002018-200730030-00005
format article
fullrecord <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_19665902</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A200343983</galeid><sourcerecordid>A200343983</sourcerecordid><originalsourceid>FETCH-LOGICAL-c441t-d814e02655a9ad77b32f1cbe71fc53790beec7315aeb1284c7202ce56d18d08f3</originalsourceid><addsrcrecordid>eNptkMtKAzEUhrNQbK2-ggyI7qbmMrnMsniHghtdh0xypkTmUpOZhW9vakeLYM4i8PP94eRDKCN4SYngNzgdionKKcaSYcxwvov4EZpjQoqcl0TM0GmM7ylVVKgTNCOSFWnwHC3vwrjJfedGCy6DzvU2-A4y07mshcFUfeNt5nzsg4MQz9BxbZoI59O9QG8P96-3T_n65fH5drXObVGQIXeKFICp4NyUxklZMVoTW4EkteVMlrgCsJIRbqAiVBVWUkwtcOGIcljVbIGu9-9uQ_8xQhx066OFpjEd9GPUpBSCl5gm8HIPbkwD2nd1PwRjd7BeJSHpk6ViiVr-Q6Vx0Hrbd1D7lP8pqH3Bhj7GALXeBt-a8KkJ1jvt-ke7_tX-HfFUvZhWH6sW3KE4OU_A1QSYaE1TB9NZHw-cEpxKytkXn3uJQw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>19665902</pqid></control><display><type>article</type><title>Drug-induced endocrine and metabolic disorders</title><source>Springer Nature:Jisc Collections:Springer Nature Read and Publish 2023-2025: Springer Reading List</source><creator>MA, Ronald C. W ; KONG, Alice P. S ; CHAN, Norman ; TONG, Peter C. Y ; CHAN, Juliana C. N</creator><creatorcontrib>MA, Ronald C. W ; KONG, Alice P. S ; CHAN, Norman ; TONG, Peter C. Y ; CHAN, Juliana C. N</creatorcontrib><description>Complex interactions exist amongst the various components of the neuroendocrine system in order to maintain homeostasis, energy balance and reproductive function. These components include the hypothalamus-pituitary- adrenal and -gonadal axes, the renin-angiotensin-aldosterone system, the sympathetic nervous system and the pancreatic islets. These hormones, peptides and neurotransmitters act in concert to regulate the functions of many organs, notably the liver, muscles, kidneys, thyroid, bone, adrenal glands, adipocytes, vasculature, intestinal tract and gonads, through many intermediary pathways. Endocrine and metabolic disorders can arise from imbalance amongst numerous hormonal factors. These disturbances may be due to endogenous processes, such as increased secretion of hormones from a tumour, as well as exogenous drug administration. Drugs can cause endocrine abnormalities via different mechanisms, including direct alteration of hormone production, changes in the regulation of the hormonal axis, effects on hormonal transport, binding, and signalling, as well as similar changes to counter-regulatory hormone systems. Furthermore, drugs can affect the evaluation of endocrine parameters by causing interference with diagnostic tests. Common drug-induced endocrine and metabolic disorders include disorders of carbohydrate metabolism, electrolyte and calcium abnormalities, as well as drug-induced thyroid and gonadal disorders. An understanding of the proposed mechanisms of these drug effects and their evaluation and differential diagnosis may allow for more critical interpretation of the clinical observations associated with such disorders, better prediction of drug-induced adverse effects and better choices of and rationales for treatment.</description><identifier>ISSN: 0114-5916</identifier><identifier>DOI: 10.2165/00002018-200730030-00005</identifier><identifier>PMID: 17343430</identifier><language>eng</language><publisher>Auckland: Adis international</publisher><subject>Biological and medical sciences ; Calcium Metabolism Disorders - chemically induced ; Drug toxicity and drugs side effects treatment ; Drug-Related Side Effects and Adverse Reactions ; Endocrine System Diseases - chemically induced ; Endocrine System Diseases - diagnosis ; Gonadal Disorders - chemically induced ; Humans ; Medical sciences ; Metabolic Diseases - chemically induced ; Metabolic Diseases - diagnosis ; Miscellaneous (drug allergy, mutagens, teratogens...) ; Pharmacology. Drug treatments ; Thyroid Diseases - chemically induced ; Water-Electrolyte Imbalance - chemically induced</subject><ispartof>Drug safety, 2007-01, Vol.30 (3), p.215-245</ispartof><rights>2007 INIST-CNRS</rights><rights>COPYRIGHT 2007 Wolters Kluwer Health, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c441t-d814e02655a9ad77b32f1cbe71fc53790beec7315aeb1284c7202ce56d18d08f3</citedby><cites>FETCH-LOGICAL-c441t-d814e02655a9ad77b32f1cbe71fc53790beec7315aeb1284c7202ce56d18d08f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=18652725$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17343430$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>MA, Ronald C. W</creatorcontrib><creatorcontrib>KONG, Alice P. S</creatorcontrib><creatorcontrib>CHAN, Norman</creatorcontrib><creatorcontrib>TONG, Peter C. Y</creatorcontrib><creatorcontrib>CHAN, Juliana C. N</creatorcontrib><title>Drug-induced endocrine and metabolic disorders</title><title>Drug safety</title><addtitle>Drug Saf</addtitle><description>Complex interactions exist amongst the various components of the neuroendocrine system in order to maintain homeostasis, energy balance and reproductive function. These components include the hypothalamus-pituitary- adrenal and -gonadal axes, the renin-angiotensin-aldosterone system, the sympathetic nervous system and the pancreatic islets. These hormones, peptides and neurotransmitters act in concert to regulate the functions of many organs, notably the liver, muscles, kidneys, thyroid, bone, adrenal glands, adipocytes, vasculature, intestinal tract and gonads, through many intermediary pathways. Endocrine and metabolic disorders can arise from imbalance amongst numerous hormonal factors. These disturbances may be due to endogenous processes, such as increased secretion of hormones from a tumour, as well as exogenous drug administration. Drugs can cause endocrine abnormalities via different mechanisms, including direct alteration of hormone production, changes in the regulation of the hormonal axis, effects on hormonal transport, binding, and signalling, as well as similar changes to counter-regulatory hormone systems. Furthermore, drugs can affect the evaluation of endocrine parameters by causing interference with diagnostic tests. Common drug-induced endocrine and metabolic disorders include disorders of carbohydrate metabolism, electrolyte and calcium abnormalities, as well as drug-induced thyroid and gonadal disorders. An understanding of the proposed mechanisms of these drug effects and their evaluation and differential diagnosis may allow for more critical interpretation of the clinical observations associated with such disorders, better prediction of drug-induced adverse effects and better choices of and rationales for treatment.</description><subject>Biological and medical sciences</subject><subject>Calcium Metabolism Disorders - chemically induced</subject><subject>Drug toxicity and drugs side effects treatment</subject><subject>Drug-Related Side Effects and Adverse Reactions</subject><subject>Endocrine System Diseases - chemically induced</subject><subject>Endocrine System Diseases - diagnosis</subject><subject>Gonadal Disorders - chemically induced</subject><subject>Humans</subject><subject>Medical sciences</subject><subject>Metabolic Diseases - chemically induced</subject><subject>Metabolic Diseases - diagnosis</subject><subject>Miscellaneous (drug allergy, mutagens, teratogens...)</subject><subject>Pharmacology. Drug treatments</subject><subject>Thyroid Diseases - chemically induced</subject><subject>Water-Electrolyte Imbalance - chemically induced</subject><issn>0114-5916</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><recordid>eNptkMtKAzEUhrNQbK2-ggyI7qbmMrnMsniHghtdh0xypkTmUpOZhW9vakeLYM4i8PP94eRDKCN4SYngNzgdionKKcaSYcxwvov4EZpjQoqcl0TM0GmM7ylVVKgTNCOSFWnwHC3vwrjJfedGCy6DzvU2-A4y07mshcFUfeNt5nzsg4MQz9BxbZoI59O9QG8P96-3T_n65fH5drXObVGQIXeKFICp4NyUxklZMVoTW4EkteVMlrgCsJIRbqAiVBVWUkwtcOGIcljVbIGu9-9uQ_8xQhx066OFpjEd9GPUpBSCl5gm8HIPbkwD2nd1PwRjd7BeJSHpk6ViiVr-Q6Vx0Hrbd1D7lP8pqH3Bhj7GALXeBt-a8KkJ1jvt-ke7_tX-HfFUvZhWH6sW3KE4OU_A1QSYaE1TB9NZHw-cEpxKytkXn3uJQw</recordid><startdate>20070101</startdate><enddate>20070101</enddate><creator>MA, Ronald C. W</creator><creator>KONG, Alice P. S</creator><creator>CHAN, Norman</creator><creator>TONG, Peter C. Y</creator><creator>CHAN, Juliana C. N</creator><general>Adis international</general><general>Wolters Kluwer Health, Inc</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T2</scope><scope>7TK</scope><scope>7U2</scope><scope>7U7</scope><scope>C1K</scope></search><sort><creationdate>20070101</creationdate><title>Drug-induced endocrine and metabolic disorders</title><author>MA, Ronald C. W ; KONG, Alice P. S ; CHAN, Norman ; TONG, Peter C. Y ; CHAN, Juliana C. N</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c441t-d814e02655a9ad77b32f1cbe71fc53790beec7315aeb1284c7202ce56d18d08f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Biological and medical sciences</topic><topic>Calcium Metabolism Disorders - chemically induced</topic><topic>Drug toxicity and drugs side effects treatment</topic><topic>Drug-Related Side Effects and Adverse Reactions</topic><topic>Endocrine System Diseases - chemically induced</topic><topic>Endocrine System Diseases - diagnosis</topic><topic>Gonadal Disorders - chemically induced</topic><topic>Humans</topic><topic>Medical sciences</topic><topic>Metabolic Diseases - chemically induced</topic><topic>Metabolic Diseases - diagnosis</topic><topic>Miscellaneous (drug allergy, mutagens, teratogens...)</topic><topic>Pharmacology. Drug treatments</topic><topic>Thyroid Diseases - chemically induced</topic><topic>Water-Electrolyte Imbalance - chemically induced</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>MA, Ronald C. W</creatorcontrib><creatorcontrib>KONG, Alice P. S</creatorcontrib><creatorcontrib>CHAN, Norman</creatorcontrib><creatorcontrib>TONG, Peter C. Y</creatorcontrib><creatorcontrib>CHAN, Juliana C. N</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Neurosciences Abstracts</collection><collection>Safety Science and Risk</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><jtitle>Drug safety</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>MA, Ronald C. W</au><au>KONG, Alice P. S</au><au>CHAN, Norman</au><au>TONG, Peter C. Y</au><au>CHAN, Juliana C. N</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Drug-induced endocrine and metabolic disorders</atitle><jtitle>Drug safety</jtitle><addtitle>Drug Saf</addtitle><date>2007-01-01</date><risdate>2007</risdate><volume>30</volume><issue>3</issue><spage>215</spage><epage>245</epage><pages>215-245</pages><issn>0114-5916</issn><abstract>Complex interactions exist amongst the various components of the neuroendocrine system in order to maintain homeostasis, energy balance and reproductive function. These components include the hypothalamus-pituitary- adrenal and -gonadal axes, the renin-angiotensin-aldosterone system, the sympathetic nervous system and the pancreatic islets. These hormones, peptides and neurotransmitters act in concert to regulate the functions of many organs, notably the liver, muscles, kidneys, thyroid, bone, adrenal glands, adipocytes, vasculature, intestinal tract and gonads, through many intermediary pathways. Endocrine and metabolic disorders can arise from imbalance amongst numerous hormonal factors. These disturbances may be due to endogenous processes, such as increased secretion of hormones from a tumour, as well as exogenous drug administration. Drugs can cause endocrine abnormalities via different mechanisms, including direct alteration of hormone production, changes in the regulation of the hormonal axis, effects on hormonal transport, binding, and signalling, as well as similar changes to counter-regulatory hormone systems. Furthermore, drugs can affect the evaluation of endocrine parameters by causing interference with diagnostic tests. Common drug-induced endocrine and metabolic disorders include disorders of carbohydrate metabolism, electrolyte and calcium abnormalities, as well as drug-induced thyroid and gonadal disorders. An understanding of the proposed mechanisms of these drug effects and their evaluation and differential diagnosis may allow for more critical interpretation of the clinical observations associated with such disorders, better prediction of drug-induced adverse effects and better choices of and rationales for treatment.</abstract><cop>Auckland</cop><pub>Adis international</pub><pmid>17343430</pmid><doi>10.2165/00002018-200730030-00005</doi><tpages>31</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0114-5916
ispartof Drug safety, 2007-01, Vol.30 (3), p.215-245
issn 0114-5916
language eng
recordid cdi_proquest_miscellaneous_19665902
source Springer Nature:Jisc Collections:Springer Nature Read and Publish 2023-2025: Springer Reading List
subjects Biological and medical sciences
Calcium Metabolism Disorders - chemically induced
Drug toxicity and drugs side effects treatment
Drug-Related Side Effects and Adverse Reactions
Endocrine System Diseases - chemically induced
Endocrine System Diseases - diagnosis
Gonadal Disorders - chemically induced
Humans
Medical sciences
Metabolic Diseases - chemically induced
Metabolic Diseases - diagnosis
Miscellaneous (drug allergy, mutagens, teratogens...)
Pharmacology. Drug treatments
Thyroid Diseases - chemically induced
Water-Electrolyte Imbalance - chemically induced
title Drug-induced endocrine and metabolic disorders
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-23T01%3A12%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Drug-induced%20endocrine%20and%20metabolic%20disorders&rft.jtitle=Drug%20safety&rft.au=MA,%20Ronald%20C.%20W&rft.date=2007-01-01&rft.volume=30&rft.issue=3&rft.spage=215&rft.epage=245&rft.pages=215-245&rft.issn=0114-5916&rft_id=info:doi/10.2165/00002018-200730030-00005&rft_dat=%3Cgale_proqu%3EA200343983%3C/gale_proqu%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c441t-d814e02655a9ad77b32f1cbe71fc53790beec7315aeb1284c7202ce56d18d08f3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=19665902&rft_id=info:pmid/17343430&rft_galeid=A200343983&rfr_iscdi=true